Parallel Advisors’s eFFECTOR Therapeutics, Inc. Common Stock EFTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-67,738
| Closed | -$19.7K | – | 3524 |
|
|
2024
Q2 | $19.7K | Hold |
67,738
| – | – | ﹤0.01% | 1994 |
|
|
2024
Q1 | $975K | Sell |
67,738
-4
| -0% | -$48 | 0.03% | 369 |
|
|
2023
Q4 | $792K | Hold |
67,742
| – | – | 0.02% | 383 |
|
|
2023
Q3 | $1.02M | Hold |
67,742
| – | – | 0.03% | 309 |
|
|
2023
Q2 | $1.41M | Hold |
67,742
| – | – | 0.05% | 258 |
|
|
2023
Q1 | $597K | Hold |
67,742
| – | – | 0.02% | 410 |
|
|
2022
Q4 | $724K | Hold |
67,742
| – | – | 0.03% | 322 |
|
|
2022
Q3 | $969K | Hold |
67,742
| – | – | 0.04% | 244 |
|
|
2022
Q2 | $2.4M | Buy |
67,742
+40,644
| +150% | +$2.46M | 0.11% | 128 |
|
|
2022
Q1 | $2.74M | Buy |
+27,098
| New | +$3.6M | 0.11% | 130 |
|
|
2021
Q3 | – | Sell |
-10
| Closed | -$2K | – | 3319 |
|
|
2021
Q2 | $2K | Buy |
+10
| New | +$2.46K | ﹤0.01% | 2642 |
|
